This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This overview explains the primary reasons stablecoins maintain stability, focusing on peg strategies, reserve health, and liquidity considerations.
19,944 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Li Lu’s Himalaya Capital is famous for a bold, value-driven stance and a striking concentration in just a few bets. T...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
Oil prices pressed higher on March 26, 2026, nearing the mid-$100s per barrel. The move highlights how current price ...
When markets wobble, investors ask a familiar question: should sell your stocks? History shows a simple rule: avoid p...
When market turbulence rises, even growth-focused firms recalibrate. Francis Financial doubles down on fixed income, ...
Your money habits shape your children's behavior more than lectures ever will. This guide shows how to model good fin...
As market nerves flare, investors look for a safe-haven that’s practical to own. This Vanguard could be a better ball...
As AI moves from training models to everyday tools, two growth stocks smarter plays stand out as durable winners. Dis...
Growth-focused SPYG has outpaced SPYV over the last decade, a trend supported by AI spending and mega-cap tech. The g...
The nation’s busiest commuter railroad will restart in phased steps after a strike ends, with riders returning to reg...
BingEx reports Q1 2026 results that reveal both momentum and headwinds. This article breaks down the key numbers, exp...